Hasten’s Acquisition of Commercial Rights for Rocephin from Roche

Marco Zingaro
Tagged:

Lenz & Staehelin advised Hasten in this transaction.Hasten Biopharmaceutic Co., Ltd acquired the commercial rights in China for Rocephin®, a long-acting, broad spectrum cephalosporin antibiotic, from Swiss multinational…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Avatar

Author: Marco Zingaro

…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here